Skip to content

An evaluation on the efficacy and safety of compound betamethasone injection in the local blockage treatment of oral erosion lichen planus: a randomized, positive controlled, parallel clinical trial

An evaluation on the efficacy and safety of compound betamethasone injection in the local blockage treatment of oral erosion lichen planus: a randomized, positive controlled, parallel clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001225
Enrollment
Unknown
Registered
2011-02-18
Start date
2011-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral lichen planus

Interventions

Group A:Blockage of triamcinolone acetonide injection
another blockage a week later if the lesion not healed
Group B:Blockage of compound betamethasone injection

Sponsors

West China College of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old; 2. Subject decided independently to participate in the study and sign informed consent ; 3. Histopathologically and clinically proved oral erosive OLP; 4. Single erosin lesion,and the lesion size not exceeding 1 square centimeter; 5. Disease-process exceeding 2 months; 6. Negative reaction to pregnancy test in women; 7. Result of a physiccal examination is normal.

Exclusion criteria

Exclusion criteria: 1. History of allergies to dexamethasone or a known history of serious drug hypersensitivities; 2. Those with other severe oral mucous diseases; 3. Those taking immunopotentiating or immunosuppressive agents during the previous 3 months; those having topical treatment of lichen planus within a week; 4. Those with severe systemic diseases or abnormal hepatic or renal function test ;a history of hepatitis C; 5. Pregnancy or intention of pregnancy or lactation or use of contraceptives of steroid hormone recently; 6. History of psychiatric disorders; 7. Lichenoid disease induced by amalgam or other drugs

Design outcomes

Primary

MeasureTime frame
lesion size, pain level;

Countries

China

Contacts

Public ContactHongmei Zhou
acomnet@126.com+86 28 85503480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026